Literature DB >> 21958369

Correlations between vaccinia-specific immune responses within a cohort of armed forces members.

Benjamin J Umlauf1, Inna G Ovsyannikova, Iana H Haralambieva, Richard B Kennedy, Robert A Vierkant, V Shane Pankratz, Robert M Jacobson, Gregory A Poland.   

Abstract

Widespread vaccination with vaccinia virus (VACV) resulted in the eradication of smallpox; however, the licensed VACV-containing vaccines are associated with adverse events (AEs), making them unsuitable for certain high-risk populations. A better understanding of the host immune response following smallpox vaccination could result in vaccines with similar immunogenicity profiles to pre-eradication vaccines with a lower incidence of AEs. To study the immune response to VACV, we recruited 1,076 armed forces members who had been vaccinated with one dose of Dryvax(®). We measured multiple VACV-specific immune responses: neutralizing antibody titer, the level of 12 secreted cytokines in peripheral blood mononuclear cell (PBMC) cultures (IL-1β, IL-2, IL-4, IL-6, IL-10, IL-12p40, IL-12p70, TNF-α, IFN-γ, IFN-α, IFN-β, and IL-18), and the number of IFN-γ- and CD8(+) IFN-γ-secreting cells. We analyzed these data to determine correlations between immune response measures. We detected a strong proinflammatory response in concert with a Th-1-like cytokine response pattern at a median time point of 15.3 mo following primary vaccination. We also detected correlations between neutralizing antibody titer and secreted IL-2, as well as secreted IFN-γ (p=0.009 and p=0.0007, respectively). We also detected strong correlations between the proinflammatory cytokines IL-1β, TNF-α, IL-6, and IL-12p40 (p<0.0001). These results further advance our knowledge of vaccinia-specific cellular immune responses. Notably, vaccine-induced proinflammatory responses were not correlated with neutralizing antibody titers, suggesting that further attenuation to reduce inflammatory immune responses may result in decreased AEs without sacrificing VACV immunogenicity and population seropositivity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21958369      PMCID: PMC3236101          DOI: 10.1089/vim.2011.0029

Source DB:  PubMed          Journal:  Viral Immunol        ISSN: 0882-8245            Impact factor:   2.257


  32 in total

1.  Dose-dependent neutralizing-antibody responses to vaccinia.

Authors:  Robert B Belshe; Frances K Newman; Sharon E Frey; Robert B Couch; John J Treanor; Carol O Tacket; Lihan Yan
Journal:  J Infect Dis       Date:  2004-01-23       Impact factor: 5.226

2.  Detection of vaccinia virus-specific IFNγ and IL-10 secretion from human PBMCs and CD8⁺ T cells by ELISPOT.

Authors:  Benjamin J Umlauf; Norman A Pinsky; Inna G Ovsyannikova; Gregory A Poland
Journal:  Methods Mol Biol       Date:  2012

3.  HLA class II alleles and measles virus-specific cytokine immune response following two doses of measles vaccine.

Authors:  Inna G Ovsyannikova; Robert M Jacobson; Jenna E Ryan; Robert A Vierkant; V Shane Pankratz; Steven J Jacobsen; Gregory A Poland
Journal:  Immunogenetics       Date:  2005-01-27       Impact factor: 2.846

4.  Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.

Authors:  Clement A Meseda; Alonzo D Garcia; Arunima Kumar; Anne E Mayer; Jody Manischewitz; Lisa R King; Hana Golding; Michael Merchlinsky; Jerry P Weir
Journal:  Virology       Date:  2005-09-01       Impact factor: 3.616

5.  Production of interferon-gamma and interleukin-10 after inactivated hepatitis A immunization.

Authors:  Mary S Hayney; Jessica M Buck; Daniel Muller
Journal:  Pharmacotherapy       Date:  2003-04       Impact factor: 4.705

6.  Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001.

Authors:  L D Rotz; D A Dotson; I K Damon; J A Becher
Journal:  MMWR Recomm Rep       Date:  2001-06-22

7.  Adverse events after smallpox immunizations are associated with alterations in systemic cytokine levels.

Authors:  Michael T Rock; Sandra M Yoder; Thomas R Talbot; Kathryn M Edwards; James E Crowe
Journal:  J Infect Dis       Date:  2004-04-05       Impact factor: 5.226

8.  Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 beta converting enzyme.

Authors:  C A Ray; R A Black; S R Kronheim; T A Greenstreet; P R Sleath; G S Salvesen; D J Pickup
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

Review 9.  Infection, fever, and exogenous and endogenous pyrogens: some concepts have changed.

Authors:  Charles A Dinarello
Journal:  J Endotoxin Res       Date:  2004

10.  Cellular and humoral immunity against vaccinia virus infection of mice.

Authors:  Rong Xu; Aaron J Johnson; Denny Liggitt; Michael J Bevan
Journal:  J Immunol       Date:  2004-05-15       Impact factor: 5.422

View more
  11 in total

1.  Race and sex-based differences in cytokine immune responses to smallpox vaccine in healthy individuals.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Richard B Kennedy; Beth R Larrabee; V Shane Pankratz; Gregory A Poland
Journal:  Hum Immunol       Date:  2013-06-24       Impact factor: 2.850

2.  Genome-wide analysis of polymorphisms associated with cytokine responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; V Shane Pankratz; Iana H Haralambieva; Robert A Vierkant; Gregory A Poland
Journal:  Hum Genet       Date:  2012-05-19       Impact factor: 4.132

3.  An interaction quantitative trait loci tool implicates epistatic functional variants in an apoptosis pathway in smallpox vaccine eQTL data.

Authors:  C A Lareau; B C White; A L Oberg; R B Kennedy; G A Poland; B A McKinney
Journal:  Genes Immun       Date:  2016-04-07       Impact factor: 2.676

4.  Genetic variation in IL18R1 and IL18 genes and Inteferon γ ELISPOT response to smallpox vaccination: an unexpected relationship.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; Megan M O'Byrne; V Shane Pankratz; Gregory A Poland
Journal:  J Infect Dis       Date:  2013-07-30       Impact factor: 5.226

Review 5.  Cytokine production associated with smallpox vaccine responses.

Authors:  Whitney L Simon; Hannah M Salk; Inna G Ovsyannikova; Richard B Kennedy; Gregory A Poland
Journal:  Immunotherapy       Date:  2014       Impact factor: 4.196

6.  Impact of cytokine and cytokine receptor gene polymorphisms on cellular immunity after smallpox vaccination.

Authors:  Inna G Ovsyannikova; Iana H Haralambieva; Richard B Kennedy; V Shane Pankratz; Robert A Vierkant; Robert M Jacobson; Gregory A Poland
Journal:  Gene       Date:  2012-08-23       Impact factor: 3.688

7.  High-dimensional gene expression profiling studies in high and low responders to primary smallpox vaccination.

Authors:  Iana H Haralambieva; Ann L Oberg; Neelam Dhiman; Inna G Ovsyannikova; Richard B Kennedy; Diane E Grill; Robert M Jacobson; Gregory A Poland
Journal:  J Infect Dis       Date:  2012-09-04       Impact factor: 5.226

8.  Proteomic assessment of humoral immune responses in smallpox vaccine recipients.

Authors:  Richard B Kennedy; Inna G Ovsyannikova; Iana H Haralambieva; Diane E Grill; Gregory A Poland
Journal:  Vaccine       Date:  2021-12-21       Impact factor: 3.641

9.  Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine.

Authors:  Iana H Haralambieva; Inna G Ovsyannikova; Benjamin J Umlauf; Robert A Vierkant; V Shane Pankratz; Robert M Jacobson; Gregory A Poland
Journal:  Vaccine       Date:  2011-09-20       Impact factor: 3.641

10.  Polymorphisms in STING Affect Human Innate Immune Responses to Poxviruses.

Authors:  Richard B Kennedy; Iana H Haralambieva; Inna G Ovsyannikova; Emily A Voigt; Beth R Larrabee; Daniel J Schaid; Michael T Zimmermann; Ann L Oberg; Gregory A Poland
Journal:  Front Immunol       Date:  2020-10-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.